Lanticse, Clemencia A.

HRN: 18-16-44  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
CEFTRIAXONE 1G (VIAL)
07/09/2026
07/15/2026
IV
2gm
Q24
Uti
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines